Telemedico’s platform currently fields over 100,000 consultations every month, and we are projecting an increase to 250,000 by end of 2021. The COVID-19 pandemic has seen a wide-scale growth in the adoption of telemedicine, which we foresee continuing long into 2021. I am particularly excited about this stage of growth for Telemedico as we will be able to service more of the world and continue to streamline the access to medicine for people when they need it most. We look forward to broadening our partnerships with online pharmacies, banks and pharmaceutical companies so that we can provide a better level of service to more patients.
Pawel Sieczkiewicz, CEO, Telemedi.co
Our portfolio companies in the last 12 months have raised over 70 mln PLN. We are thrilled to continue supporting Paweł and the Telemedico team on the journey to become a leading digital health company in the region. Being involved in the company since our initial seed investment, we have seen the team grow, execute and expose a deep understanding of the structural changes concerning healthcare that happen right before our eyes. We are excited to welcome new investors as part of Telemedico’s story and are looking forward to what the future holds for the company.
Marcin P. Kowalik, Managing Partner, Black Pearls VC